| HYBB | JNK | HYBB / JNK | |
| Gain YTD | 1.582 | 1.829 | 87% |
| Net Assets | 401M | 7.7B | 5% |
| Total Expense Ratio | 0.25 | 0.40 | 63% |
| Turnover | 27.00 | 49.00 | 55% |
| Yield | 5.86 | 6.59 | 89% |
| Fund Existence | 6 years | 19 years | - |
| HYBB | JNK | |
|---|---|---|
| RSI ODDS (%) | N/A | N/A |
| Stochastic ODDS (%) | 3 days ago 49% | 3 days ago 65% |
| Momentum ODDS (%) | 3 days ago 59% | 3 days ago 59% |
| MACD ODDS (%) | 3 days ago 54% | 3 days ago 63% |
| TrendWeek ODDS (%) | 3 days ago 51% | 3 days ago 51% |
| TrendMonth ODDS (%) | 3 days ago 47% | 3 days ago 49% |
| Advances ODDS (%) | 3 days ago 50% | 3 days ago 53% |
| Declines ODDS (%) | 12 days ago 48% | about 1 month ago 52% |
| BollingerBands ODDS (%) | 3 days ago 62% | 3 days ago 67% |
| Aroon ODDS (%) | 3 days ago 58% | 3 days ago 51% |
| 1 Day | |||
|---|---|---|---|
| MFs / NAME | Price $ | Chg $ | Chg % |
| JIREX | 13.98 | 0.17 | +1.23% |
| JHancock Real Estate Securities 1 | |||
| ESPAX | 39.56 | 0.38 | +0.97% |
| Allspring Special Small Cap Value A | |||
| VGIAX | 118.33 | 0.62 | +0.53% |
| Vanguard Growth & Income Adm | |||
| FTDZX | 184.49 | 0.95 | +0.52% |
| Franklin Biotechnology Discovery Adv | |||
| APWIX | 13.33 | 0.04 | +0.30% |
| AB Sustainable Thematic Bal Port I | |||
A.I.dvisor tells us that JNK and DBD have been poorly correlated (+33% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that JNK and DBD's prices will move in lockstep.
| Ticker / NAME | Correlation To JNK | 1D Price Change % | ||
|---|---|---|---|---|
| JNK | 100% | +0.02% | ||
| DBD - JNK | 33% Poorly correlated | +0.11% | ||
| WFRD - JNK | 25% Poorly correlated | +0.28% | ||
| AMPY - JNK | 13% Poorly correlated | -0.91% | ||
| GPOR - JNK | -4% Poorly correlated | +2.42% |